Summary
- Current Price
- As of today, TVTX price is $56.02, up +1.89% on
- Current Price All-Time High
- TVTX price is currently -6.79% below its historical high of $60.10 set on
- Market Cap
- TVTX current market cap is $5B, up +266.33% over the past 365 days
- Revenue
- TVTX current annual revenue is $490.73M, up +110.45% year-over-year
- Next Earnings
- The next earnings release for TVTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Travere Therapeutics, Inc. |
| Ticker | NASDAQ: TVTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | travere.com |
| Employees | 385 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $56.02 | |
| Price, 1D Change | +1.89% | |
| $5B | ||
| - | ||
| - | ||
| 1.52 | ||
| $491M | ||
| Revenue, 1Y Change | +110.45% | |
| -$0.56 | ||
| EPS, 1Y Change | +86.18% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:9 | |
| Next Split | N/A | N/A |
| Last Ticker Change | RTRX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.56 | ||
| EPS Estimate | N/A | $1.97 |
| EPS Est. Change | N/A | +449.41% |
| $490.73M | ||
| Revenue Estimate | N/A | $679.11M |
| Revenue Est. Change | N/A | +38.39% |
| Current Price | $56.02 | |
| Price Target | - | $60.50 |
| Price Tgt. Change | - | +8.00% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.84 | -$4.08 | -43.71% | |
| $0.89 | -$0.56 | -163.00% | |
| $1.97 | N/A | +449.41% | |
| $4.88 | N/A | +965.39% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $231.13M | $233.18M | +0.88% | |
| $508.40M | $490.73M | -3.48% | |
| $679.11M | N/A | +38.39% | |
| $974.32M | N/A | +98.55% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $56.02 | |
| $38.65 | ||
| $53.54 | ||
| $39.97 | ||
| $52.88 | ||
| $0.65 | ||
| 1.52 | ||
| $2.46 | ||
| 55.23 | ||
| 27.83% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $490.73M | ||
| -$0.56 | ||
| $419.65M | ||
| 85.52% | ||
| -$62.82M | ||
| -12.80% | ||
| -$50.26M | ||
| -10.24% | ||
| -$2.08M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 2.86 | ||
| 2.74 | ||
| 2.70 | ||
| - | ||
| 6 | ||
| 3.99 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 9.72 | ||
| 52.77 | ||
| 327.66 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $114.83M | ||
| $322.80M | ||
| $605.19M | ||
| $437.57M | ||
| $490.36M | ||
| $159.90M | ||
| $328.73M | ||
| $5.88M | ||
| $24.80M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $540.99M | ||
| $482.47M | ||
| $71.08M | ||
| $337.20M | ||
| $60.74M | ||
| $0.00 | ||
| $988.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $37.78M | ||
| $27.89M | ||
| -$33.47M | ||
| $58.16M | ||
| -$20.37M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | → | |
| Guggenheim | → | |
| Wedbush | → | |
| Evercore ISI Group | → | |
| Citigroup | → | |
| Wells Fargo | → | |
| Wedbush | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with TVTX
FAQ
- What is the ticker symbol for Travere Therapeutics, Inc.?
- The ticker symbol for Travere Therapeutics, Inc. is NASDAQ:TVTX
- Does Travere Therapeutics, Inc. pay dividends?
- No, Travere Therapeutics, Inc. does not pay dividends
- What sector is Travere Therapeutics, Inc. in?
- Travere Therapeutics, Inc. is in the Healthcare sector
- What industry is Travere Therapeutics, Inc. in?
- Travere Therapeutics, Inc. is in the Biotechnology industry
- What country is Travere Therapeutics, Inc. based in?
- Travere Therapeutics, Inc. is headquartered in United States
- When did Travere Therapeutics, Inc. go public?
- Travere Therapeutics, Inc. initial public offering (IPO) was on November 8, 2012
- Is Travere Therapeutics, Inc. in the S&P 500?
- No, Travere Therapeutics, Inc. is not included in the S&P 500 index
- Is Travere Therapeutics, Inc. in the NASDAQ 100?
- No, Travere Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Travere Therapeutics, Inc. in the Dow Jones?
- No, Travere Therapeutics, Inc. is not included in the Dow Jones index
- When was Travere Therapeutics, Inc. last earnings report?
- Travere Therapeutics, Inc.'s most recent earnings report was on May 4, 2026
- When does Travere Therapeutics, Inc. report earnings?
- The next expected earnings date for Travere Therapeutics, Inc. is August 4, 2026
Data Sources & References
- TVTX Official Website www.travere.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1438533/000143853326000014/0001438533-26-000014-index.htm
- TVTX Profile on Yahoo Finance finance.yahoo.com/quote/TVTX
- TVTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tvtx